NCT07149129Enrolling by invitation
Biofeedback After Stroke
Use of Electromyographic Biofeedback in Upper Limb Rehabilitation After Stroke
Source: ClinicalTrials.gov · Last updated 29 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Studies show that the use of electromyographic biofeedback combined with other therapies contributes to the reduction of upper limb spasticity after stroke. However, there is a lack of literature regarding the best protocols to use in clinical practice, as well as functional outcomes after this therapy. The objective of this research project will be to investigate the effect of electromyographic biofeedback on spasticity in individuals post-stroke in the sub-acute phase, and its outcomes regarding upper limb function and participation in activities of daily living. The study will be a randomized, triple-blind clinical trial in which the 45 participants will be divided into two groups: the experimental group will receive electromyographic biofeedback combined with functional training, and the control group will receive functional training with placebo biofeedback alone. The study hypothesis is that the use of electromyographic biofeedback contributes to improved functional outcomes and participation in activities of daily living in patients with upper limb spasticity resulting from stroke.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- First submitted
- 14 Aug 2025
- Start date
- 1 Aug 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Universidade Federal do Paraná
- Diseases
- Stroke
- NCT number
- NCT07149129
What you commit to
- Study type: Interventional
- Planned participants: 45
- From 1 Aug 2025 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- botulinum toxin/phenol injections within the previous 5 months
- medications that reduce muscle tone
Other
- Other neurological impairments or trauma-orthopedic deformities in the upper limbs
- aphasia that prevents basic communication
- low vision or low visual acuity that prevents them from viewing the screen.
Who the study is looking for
- Patients with a clinical diagnosis of stroke (imaging tests and a medical report)
- Spasticity with an Ashworth score equal to or less than 3 in the upper limb
- 20-60 years old
Age in the registry: 20 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universidade Tecnológica Federal do Paraná Coordinator of this site? Confirm its status | Curitiba | Brazil | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.